The fate of the Blal repressor during the induction of the Bacillus licheniformis BlaP beta-lactamase by Filée, Patrice et al.
© 2002 Blackwell Science Ltd
The fate of the BlaI repressor during the induction of
the Bacillus licheniformis BlaP b-lactamase
penicillin stress is also required for full induction of
b-lactamase biosynthesis.
Introduction
The Bacillus licheniformis 749/I BlaP and Staphylococcus
aureus BlaZ class A b-lactamases are inducible by b-
lactam antibiotics (Joris et al., 1994; Philippon et al.,
1998). In both strains, b-lactamase expression is under
the control of two gene products, BlaI and BlaR1, which
are a repressor and a penicillin-sensory transducer
respectively (Kobayashi et al., 1987; Nicholls and
Lampen, 1987; Rowland and Dyke, 1990) At the DNA
level, blaZ/blaP, blaR1 and blaI are organized as a diver-
gon (bla divergon) in which blaR1 and blaI form an
operon. It has been shown that purified BlaI is present as
a dimer in solution, that the DNA-binding domain is
located near the N-terminal end and that the dimerization
domain is in the C-terminal region (Wittman et al., 1993).
In the absence of b-lactam, both b-lactamase synthesis
and expression of the blaI–blaR1 operon are maintained
at a low level by the BlaI repressor (Salerno and Lampen,
1988; Clarke and Dyke, 2001). Binding of a b-lactam 
to BlaR1 causes derepression and a high level of b-
lactamase synthesis (Joris et al., 1990; Zhu et al., 1992).
The low-affinity penicillin-binding protein 2¢ (MecA protein)
of S. aureus is under the control of the MecI and MecR
proteins, which are similar to the corresponding BlaI and
BlaR1 b-lactamase regulators. The membrane topology
of B. licheniformis BlaR1 has been determined and high-
lights the amino acid sequence signature of a neutral zinc
metallopeptidase in the intracellular B4 loop (Hardt et al.,
1997). This motif is conserved in MecR/BlaR1 and is
essential for the induction process (Zhang et al., 2001; K.
Benlafya and B. Joris, unpublished data). Earlier results
obtained using classical genetic experiments suggested
that, in both S. aureus and B. licheniformis, an additional
blaR2 gene was involved in b-lactamase or MecA induc-
tion (Sherratt and Collins, 1973; Dyke, 1979). The trans-
formation of Bacillus subtilis BD224, a strain devoid of
blaP, blaR1 and blaI, by a Bacillus plasmid harbouring the
B. licheniformis bla divergon gives rise to an inducible
BlaP b-lactamase phenotype, indicating that all the genes
needed for the induction are present in the recombinant
B. subtilis strain (Kobayashi et al., 1987). Consequently,
if BlaR2 is important for b-lactamase induction, an equiv-
alent blaR2 gene must be present in the B. subtilis
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Summary
The induction of the Staphylococcus aureus BlaZ 
and Bacillus licheniformis 749/I BlaP b-lactamases 
by b-lactam antibiotics occurs according to similar
processes. In both bacteria, the products of the 
blaI and blaR1 genes share a high degree of sequence
homology and act as repressors and penicillin-
sensory transducers respectively. It has been shown
in S. aureus that the BlaI repressor, which controls
the expression of BlaZ negatively, is degraded 
after the addition of the inducer. In the present study,
we followed the fate of BlaI during b-lactamase induc-
tion in B. licheniformis 749/I and in a recombinant
Bacillus subtilis 168 strain harbouring the pDML995
plasmid, which carries the B. licheniformis blaP, 
blaI and blaR1 genes. In contrast to the situation in
B. licheniformis 749/I, b-lactamase induction in B.
subtilis 168/pDML995 was not correlated with the 
proteolysis of BlaI. To exclude molecular variations
undetectable by SDS–PAGE, two-dimensional gel
electrophoresis was performed with cellular extracts
from uninduced or induced B. subtilis 168/pDML995
cells. No variation in the BlaI isoelectric point was
observed in induced cells, whereas the DNA-binding
property was lost. Cross-linking experiments with
dithiobis(succimidylpropionate) confirmed that, in
uninduced recombinant B. subtilis cells, BlaI was
present as a homodimer and that this situation 
was not altered in induced conditions. This latter
result is incompatible with a mechanism of inactiva-
tion of BlaI by proteolysis and suggests that the 
inactivation of BlaI results from a non-covalent 
modification by a co-activator and that the sub-
sequent proteolysis of BlaI might be a secondary 
phenomenon. In addition to the presence of this 
co-activator, our results show that the presence of
Accepted 14 January, 2002. *For correspondence. E-mail
bjoris@ulg.ac.be; Tel. (+32) 366 2954; Fax (+32) 366 3364.
genome. Moreover, the Bacillus blaP and blaI–blaR1 
promoters are functional in a recombinant Escherichia
coli strain, but the b-lactamase is not inducible in the 
presence of penicillin (Kobayashi et al., 1987).
Recently, Zhang et al. (2001) proposed a mechanism
for the induction of b-lactam resistance in Staphylococci.
According to these authors, the acylation of the penicillin
receptor BlaR1 by the inducer generates a cleavage of
the cytoplasmic loop B4, which would convert this puta-
tive metalloprotease to its active form. Next, the activated
B4 loop would generate a secondary signal, which would
result in the proteolysis of BlaI. The proteolytic cleavage
of S. aureus BlaI takes place between the N101 and F102
residues, generates two fragments (an 11 kDa fragment
containing the DNA-binding domain and a 3 kDa fragment
corresponding to the dimerization domain) and inactivates
BlaI, which no longer acts as a repressor. However, the
induction process does not cleave BlaI completely, and it
was suggested that a heterodimer containing the wild-
type monomer and the free dimerization domain could 
be present in the cytoplasm of induced cells and that this
heterodimer did not bind to DNA (Gregory et al., 1997;
Lewis et al., 1999).
Two different B. licheniformis 749/C strains that consti-
tutively produce b-lactamase have been described. In
these two strains, sequence analysis revealed that the
mutation responsible for this phenotype was located in
blaI. In one strain, the mutation results in an early termi-
nation of BlaI translation (Grossman and Lampen, 1987)
and, in the second, the mutated repressor differs from the
wild-type BlaI by three mutations; S34 Æ P and M97
V98 Æ I L (Wittman and Wong, 1988). For the latter
mutant, the two mutations have been separated, and the
two derived mutants, BlaI S34 Æ P and BlaI M97 V98 Æ I
L, have been tested for their ability to repress the expres-
sion of the b-galactosidase gene fused to the blaP pro-
moter in E. coli. In this strain, the individual mutations are
not sufficient to inactivate the repressor, and it was con-
cluded that a combination of the mutations is necessary
for the inactivation of the repressor. But surprisingly, in a
recombinant B. subtilis, the BlaI M97 V98 Æ I L mutation
(BlaI-GM2) resulted in magnoconstitutive b-lactamase
expression (T. Kobayashi, unpublished). The difference
between the two hosts remains unexplained.
In this study, we describe the expression of wild-
type BlaI and the BlaI-GM2 mutant in E. coli and their
purification. We used Western blot, two-dimensional 
electrophoresis, bandshift assays and intermolecular
cross-linking to analyse the fate of B. licheniformis BlaI or
BlaI-GM2 during BlaP b-lactamase induction in wild-type,
blaR1– and blaR2– B. licheniformis strains or in a recom-
binant B. subtilis strain harbouring a plasmid carrying the
B. licheniformis bla divergon. This work reveals that, in a
recombinant B. subtilis, BlaI is not cleaved during the
induction process. We provide experimental evidence that
BlaI is always present as a homodimer in both uninduced
and induced conditions. This result suggests that the inac-
tivation of BlaI is mediated by a specific co-activator gen-
erated by the ‘activated’ BlaR1 and that BlaI proteolysis
is a secondary phenomenon resulting from the activity of
cytoplasmic proteases. Finally, the fate of BlaI-GM2 in the
presence of wild type or inactivated BlaR1 receptor con-
firms this hypothesis and emphasizes that, in addition to
the acylation of BlaR1, an intracellular factor generated
by a penicillin stress is required for full derepression of 
b-lactamase biosynthesis.
Results
Production and purification of B. licheniformis BlaI
The purified BlaI-WT and BlaI-GM2 repressors were
analysed by gel retardation using a fluorescent oligo and
an ALFexpress sequencer. The results indicate that BlaI-
GM2 retains its ability to bind the blaP operator but that
its affinity for its DNA target is reduced compared with
BlaI-WT. Indeed, in the same experimental conditions, the
BlaI-GM2 concentration necessary to obtain the same
bound:free DNA ratio is threefold higher than that of BlaI-
WT (Fig. 1). To demonstrate that BlaI-GM2 has retained
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Fig. 1. DNA-binding assays with purified BlaI-
WT and BlaI-GM2. The OP1 DNA fluorescent
probe (0.5 ¥ 10–8 M) was incubated with
purified BlaI-WT (6.6 ¥ 10–8 M) or BlaI-GM2
(1.9 ¥ 10–7 M). Free and bound represent 
free OP1 and the DNA–protein complex
respectively. On the basis of the peak areas,
the ratios of bound/total DNA are equal (0.72)
for the BlaI-WT and BlaI-GM2 DNA
complexes.
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its ability to dimerize, the mutant repressor was incubated
with the homobifunctional reagent dithiobis succimidyl-
propionate (DSP). As shown by SDS–PAGE in Fig. 2,
purified BlaI-GM2 was present as a single 12 kDa band in
the absence of DSP. After treatment with DSP, an addi-
tional band was detected with a molecular size corre-
sponding to that of the dimer form of BlaI-WT (28 kDa).
This result indicates that, in our experimental conditions,
the BlaI-GM2 mutant retains its ability to dimerize. The
limitations of the method do not allow us to detect modi-
fications of the dimer association constant.
Construction of the Bacillus/ E. coli shuttle plasmid
carrying blaI-GM2 in the bla divergon and b-lactamase
induction in B. subtilis 168
The blaI-GM2 mutation was introduced in the bla diver-
gon as described in Experimental procedures, and the
resulting Bacillus/E. coli shuttle plasmid pCIP158 was
transferred to B subtilis 168 and assayed for b-lactamase
induction. The b-lactamase production in B. subtilis/
pCIP158 was nearly 25-fold higher than in the wild type
under uninduced conditions. This level of production is
half that obtained for an induced B. subtilis strain har-
bouring the wild-type bla divergon (B. subtilis/pDML995).
In addition, in the presence of inducer (2.5 mg ml–1
cephalosporin C), the mutant divergon did not confer the
inducible phenotype to the host.
Bandshift assay and time course of blaI expression
during induction of B. licheniformis and recombinant 
B. subtilis strains
Western blot analysis of induced and uninduced B.
licheniformis 749/I cellular extracts showed that, in
induced conditions, the band corresponding to BlaI-WT
was not detected (Fig. 3A). In agreement, no DNA-binding
activity of BlaI-WT was observed by bandshift assay in
induced cellular extracts (Fig. 3E). Moreover, experiments
carried out with cellular extracts of BlaR1– and BlaR2–
non-inducible strains confirmed that, in both strains, the
presence of the inducer did not inactivate BlaI-WT, which
could be detected by Western blotting and bandshift
assays. (Fig. 3B, C, F and G). Surprisingly, in the recom-
binant B. subtilis/pDML995, the apparent molecular mass
of BlaI-WT under induced and uninduced conditions 
was identical to that of the purified BlaI-WT (Fig. 3D). In
addition, in the induced culture, an increased quantity of
BlaI-WT was observed, with a maximum 3 h after the addi-
tion of the inducer (Fig. 3D). To exclude undetectable
(<1.5 kDa) proteolysis of BlaI-WT during the induction
process, the BlaI-WT isoelectric point (pI) was probed by
two-dimensional gel electrophoresis. Indeed, the N- and
C-terminal BlaI-WT sequences are rich in charged re-
sidues, and a cleavage of 2–10 residues would give rise
to a modification of its pI (predicted values for truncated
BlaI-WT species range from 6.7 to 10.5 instead of 7.9 
for intact BlaI-WT). No modification of BlaI-WT pI was ob-
served even upon co-electrophoresis of BlaI-WT from in-
duced and uninduced cells, the protein being detected as
a single spot by anti-BlaI antibodies (Fig. 4). To demon-
strate that dimerization of BlaI-WT is not modified during
BlaP b-lactamase induction, intermolecular cross-linking
experiments were carried out using DSP as cross-linking
agent. Incubation of a dilute solution of purified BlaI (17
mM) with DSP (20 mM) resulted in the specific formation
of a 28 kDa adduct as a result of the cross-linked BlaI-WT
dimer (Fig. 2). In cellular extracts of uninduced and
induced B. subtilis/pDML995 strains, the same result was
obtained (Fig. 5).
For B. subtilis/pCIP158, BlaI antibodies detect two 
BlaI-GM2 species in the cellular extract corresponding to
12 kDa and 10 kDa, respectively, a degradation pattern
similar to that obtained for S. aureus BlaI during b-
lactamase induction (Fig. 6). Thus, the behaviour of the
B. subtilis/pCIP158 strain indicates that the proteolysis of
BlaI does not necessarily rest on the presence of the
inducer in the medium. To highlight that the hydrolysis of
BlaI-GM2 is BlaR1 independent, the zinc-binding motif
H212EXXH, present in the B4 cytoplasmic loop of BlaR1,
has been mutated in AAXXA in pCIP158 to generate
pCIP159. With wild-type BlaI, this mutation, as in
S. aureus, gives rise to a non-inducible b-lactamase phe-
notype (data not shown). Surprisingly, the BlaR1 mutation
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Fig. 2. BlaI-WT and BlaI-GM2 form dimers in vitro. SDS–PAGE
analysis of purified BlaI-WT or BlaI-GM2 (17 mM) before (lanes 4
and 6) and after treatment with 20 mM DSP (lanes 5 and 7). To
check the specificity of the experimental conditions for protein
dimerization, hen egg white lysozyme (17 mM, lane 2), known to be
a monomeric protein in solution, was treated with DSP (lane 3) and
used as negative control. Mr standards were loaded in lane 1.
complements the BlaI-GM2 mutant and restores the
inducibility of the b-lactamase in B. subtilis/pCIP159. In
the double mutant, for uninduced cells, the level of b-
lactamase expression is identical to that obtained with the
wild-type divergon. On the contrary, in the presence of
inducer, b-lactamase expression is lower than that
obtained with the wild-type operon, and the induction
factor is 12 instead of 53 for the wild-type operon
(Fig. 7A). The analysis of the fate of BlaI-GM2 during the
induction process shows that the mutant repressor is not
proteolysed during the induction phenomenon (Fig. 7B).
Discussion
The BlaI repressor has two functional domains. The
amino-terminal domain is responsible for operator re-
cognition, and the carboxy-terminal domain is involved in
subunit dimerization. The formation of the BlaI dimer is
necessary for repressor activity, and C-terminal truncated
BlaI is unable to both dimerize and bind DNA (Wittman
et al., 1993). Many studies have reported the proteolysis
of the BlaI repressor during the induction of the BlaZ b-
lactamase in S. aureus. The cleavage site has been local-
ized between residues N101 and F102. It was postulated
© 2002 Blackwell Science Ltd, Molecular Microbiology, 44, 685–694
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Fig. 3. Fate of BlaI during an induction time course. Western blot analyses of cellular extracts prepared from induced B. licheniformis 749/I
(50 mg of proteins, A), B. licheniformis 110/pen-27 (blaR1–) (50 mg of proteins, B), B. licheniformis 110/pen31 (blaR2–) (50 mg of proteins, C) and
B. subtilis/pDML995 (25 mg of proteins, D) were performed as described (Experimental procedures) using anti-BlaI antibodies. Lane numbers
correspond to the number of hours elapsed after the initiation of induction by the addition of cephalosporin C (2.5 mg ml–1). For each strain, the
ability of BlaI-WT to bind DNA was probed by bandshift assay as described in Fig. 1 (E, B. licheniformis 749/I; F, B. licheniformis 110/pen-27;
G, B. licheniformis 110/pen31; H, B. subtilis/pDML995; NI, non-induced; I, induced; Free, free fluorescent Op1; Bound, BlaI-WT and Op1
complex).
Fig. 4. Two-dimensional gel electrophoresis of cellular extracts of 
a mixture of uninduced (50 mg ml–1) and induced (50 mg ml–1) B.
subtilis/pDML995. Proteins were extracted from cells induced for 
2 h with 2.5 mg ml–1 cephalosporin C; they were analysed by
isoelectric focusing (first dimension) using a pH range from 6 to 11
followed by SDS–PAGE (8–18% gradient; second dimension).
Proteins were transferred to a PVDF membrane before revelation
by anti-BlaI antibodies.
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that this cleavage, directly or indirectly mediated by
BlaR1, inhibits BlaI dimerization and reduces the affinity
of BlaI for its DNA target so that it can no longer act as a
repressor (Gregory et al., 1997; Zhang et al., 2001). In all
these studies, however, it is clear that induction does not
completely hydrolyse the repressor, and 40–50% of the
intact form is always present. Two hypotheses have 
been proposed to explain these results: (i) some of the
bacteria in the population are no longer inducible; and (ii)
a heterodimer consisting of the dimerization domain of
BlaI (102–128) and the intact BlaI is unable to act as a
repressor.
Based on amino acid sequence alignments (data not
shown), the B. licheniformis and S. aureus BlaI repres-
sors are 37% identical. The site of staphylococcal 
cleavage (N101 F102) is also present in the Bacillus
sequence, and the four upstream residues are highly con-
served in both primary structures [S97(M/L)VLNF102 in
the S. aureus BlaI numbering, B. licheniformis BlaI being
one residue shorter at its N-terminal end]. In this study,
we have shown that the BlaI repressor is completely
degraded during b-lactamase induction in wild-type B.
licheniformis 749/I but remains intact when induction is
carried out in a recombinant B. subtilis strain in which the
B. licheniformis divergon has been cloned (B. subtilis/
pDML995). Our results appear to rule out the hypothesis
that inactivation of BlaI during the induction process
results from a proteolytic cleavage. Two-dimensional elec-
trophoresis of B. subtilis/pDML995 cellular extracts
revealed that, in the presence of inducer, the pI of BlaI is
not modified. This result excludes N- and C-ragged ends
of BlaI (see Results) and is consistent with the observa-
tion that BlaI is not cleaved during induction. Interestingly,
cross-linking experiments with DSP highlighted the fact
that BlaI retains its ability to form homodimers during 
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Fig. 5. In induced conditions, BlaI-WT retains its ability to form
dimers. Western blotting of cellular extracts (50 mg of total proteins)
of uninduced and induced B. subtilis/pDML995 strain were treated
with increasing concentrations of DSP ranging from 0.5 to 2 mM.
Lane 1, Mr standards; lanes 2, 4 and 6 and lanes 3, 5 and 7
correspond to non-induced (NI) and induced (I) cellular extracts
respectively.
Fig. 6. BlaI-GM2 is proteolysed in uninduced B. subtilis/pCIP158.
Western blotting analysis of cellular extracts (lane 1, 25 mg of total
proteins), purified BlaI-WT (lane 3) and Mr standards (lane 2).
Fig. 7. A. Induction of b-lactamase synthesis in B.
subtilis/pDML995 (closed circles, wild-type bla divergon), B.
subtilis/pCIP158 (open circles, bla divergon carrying blaI-GM2
mutant) and B. subtilis/pCIP159 (filled inverted triangles, bla
divergon carrying blaI-GM2 and inactivated blaR1). Cephalosporin
C (2.5 mg ml–1) was added as inducer at time zero. The b-lactamase
activity is expressed as nmol of chromogenic substrate hydrolysed
min–1 per unit of cell density. Cell densities were estimated by
measuring the A600 of the cultures.
B. Induction is not correlated to BlaI-GM2 proteolysis. Western
blotting analysis of cellular extracts (25 mg of total proteins); lane 1,
B. subtilis/pCIP158; lanes 2 and 3, uninduced and induced B.
subtilis/pCIP159 respectively.

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Fig. 8. Tentative models explaining the behaviour of cells producing mutant and wild-type BlaI and BlaR1.
A. Inactivated BlaR1 and BlaI-GM2; in the presence of penicillin stress, the concentration of pro-co-activator increases in the cell, resulting in
a displacement of BlaI-GM2 from its operator (Op) sequence.
B. Wild-type BlaR1 and BlaI-GM2; the residual activity of BlaR1 produces a small amount of co-activator and, because of the sensitivity of
BlaI-GM2–co-activator complex to proteases, a cyclic degradation of BlaI-GM2 is initiated resulting in magnoconstitutive b-lactamase
production.
C. Wild-type bla operon; in uninduced conditions, the situation is as in (B), but the BlaI–co-activator complex is not protease sensitive, so that
no BlaI degradation cycle occurs under induced conditions; BlaR1 is activated and penicillin stress increases the concentration of pro-co-
activator, resulting in high production of co-activator and high b-lactamase expression.
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b-lactamase induction. These results and the absence of
BlaI DNA-binding activity in cell lysates derived from
induced cells suggest the presence of a ligand acting as
a co-activator that could displace the BlaI dimer from its
DNA operator target, as described for the TetR repressor
involved in the regulation of tetracycline resistance in
Gram-negative bacteria (Orth et al., 2000). Indeed,
binding of tetracycline to the C-terminal domain of the
homodimer repressor induces conformational changes
that increase the distance between the two N-terminal
binding domains of the dimer by 3 Å, abolishing the affin-
ity of TetR for its operator DNA. Similarly, the binding of
the putative ligand by BlaI could induce a conformational
change in the repressor, leading to a decrease in its affin-
ity for its DNA target and, in the case of S. aureus and B.
licheniformis, an increase in its susceptibility to the action
of the cytoplasmic proteases.
The BlaI-GM2 mutation results in high-level constitutive
production of b-lactamase in B. subtilis/pCIP158, whereas
the mutant repressor is functional in E. coli. Compared
with BlaI-WT, the affinity of BlaI-GM2 for the operator
appears to be decreased by a factor of about three (Fig. 1)
and, within the limits of the method, the DSP cross-linking
experiment seems to show that its ability to dimerize is
slightly altered (Fig. 2). Indeed, under the same experi-
mental conditions, the intensity of the BlaI-GM2 cross-
linked band is lower than that of the wild-type band.
Western blotting experiments indicate that the mutated
repressor is partially degraded in B. subtilis/pCIP158
(Fig. 2). But the most striking features are: (i) the blaI-
GM2 proteolysis is linked to the presence of a functional
BlaR1 receptor; (ii) an inactivated BlaR1 receptor restores
the inducibility of the b-lactamase (Fig. 7A); and (iii) in this
case, induction of the b-lactamase is not accompanied by
proteolysis of BlaI-GM2. If the last result appears to
confirm the hypothesis that induction is not a conse-
quence of the degradation of the repressor, the constitu-
tive production of b-lactamase in the presence of the
wild-type BlaR1 and BlaI-GM2 repressor, which is accom-
panied by partial proteolysis of the latter, seems to con-
tradict this hypothesis and is more difficult to rationalize.
Taken together, the results indicate that the presence of
penicillin outside the cell generates a signal into the cyto-
plasm that can be sensed by the mutant BlaI-GM2 repres-
sor but not by the wild-type BlaI, because a non-functional
BlaR1 associated with a wild-type BlaI gives rise to a non-
inducible phenotype (Zhu et al., 1992). A possible expla-
nation is given below, but we are perfectly conscious of
the fact that it involves several assumptions. The main
one is that a precursor of the co-activator (the pro-co-
activator) is normally present in the cells at a very low 
concentration and that it is the substrate of BlaR1. The
behaviour of the cells producing BlaI-GM2 but devoid of
a functional BlaR1 is examined first. In the absence of
penicillin stress, the intracellular concentration of pro-co-
activator remains low, and it cannot displace BlaI-GM2
from its operator sequence, resulting in very low b-
lactamase expression. Penicillin stress increases the 
pro-co-activator concentration, a process in which BlaR2
is involved. In contrast to the wild-type BlaI, BlaI-GM2
exhibits a non-negligible affinity for the pro-co-activator,
sufficient to induce b-lactamase expression (Fig. 8A). To
explain the constitutive expression in cells containing
BlaI-GM2 and wild-type BlaR1, it is assumed that the
latter exhibits a residual activity on the pro-co-activator,
as observed in the case of many proenzymes that are not
completely devoid of activity, and that the co-activator dis-
places BlaI-GM2 from its operator sequence (Fig. 8B). But
the BlaI-GM2–co-activator complex is sensitive to the B.
subtilis cytoplasmic proteases, regenerating the free co-
activator and initiating a binding/proteolysis cycle in which
a small amount of co-activator can be responsible for the
degradation of an important proportion of BlaI-GM2. In
contrast, the wild-type BlaI–co-activator complex is pro-
tease stable, so that, in uninduced conditions, the co-
activator concentration is not sufficient significantly to 
displace BlaI from its operator sequence. Full induction
then results from two consequences of the presence of
penicillin: the activation of BlaR1 thanks to the acylation
of its C-terminal domain and the increase in the intracel-
lular pro-co-activator concentration as a result of penicillin
stress.
Experimental procedures
Bacterial strains, plasmids and DNA manipulations
Bacillus licheniformis 749/I, 110/pen-27 and 110/pen-31 were
wild-type, blaR1– and blaR2– strains respectively (Zhu et al.,
1992). E. coli DH5a (Invitrogen) or B. subtilis 168 (ATCC
23857) were used as recipients of recombinant plasmids. 
E. coli GI724 (Invitrogen), carrying the cI l repressor gene
under the control of the trp promoter, and E. coli BL21 (DE3)
(Novagen) were used as hosts for the overexpression of 
BlaI-WT and BlaI GM2 respectively.
The plasmids used in this study are listed in Table 1.
Plasmid pRTW8 (Kobayashi et al., 1987) was the source of
the wild-type B. licheniformis 749/I blaP, blaI and blaR1
genes. Plasmid pDML995 (A. Brans, unpublished data) is a
derivative of pMK4 (Sullivan et al., 1984), in which a 3.5 kb
fragment of pRTW8 containing the B. licheniformis 749/I bla
divergon is inserted in the SalI–SmaI site.
pLex (Invitrogen), containing the l pL promoter under the
control of the CI l repressor, was used as a vector for the
overexpression of the blaI-WT product. A 400 bp fragment
covering the blaI gene was amplified by polymerase chain
reaction (PCR) using pRTW8 as template and the following
oligonucleotides as primers: 5¢-ATACATATGAAAAAAATAC
CTCAAATCTCTG-3¢ (BlaINdeI) and 5¢-ATAGAATTCATT
TCATTCCTTCTTTCTGTTCTTATG-3¢ (BlaIEcoRI). These
created NdeI and EcoRI restriction sites in the ATG start
codon and after the stop codon of blaI respectively. The
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Table 1. Plasmids used in this study.
Plasmids Source or reference
pUC18 Cloning plasmid Amersham Pharmacia
PCRScript Plasmid allowing cloning of PCR fragments Stratagene
pET22b Plasmid allowing gene expression from inducible T7 promoter Novagen
pLex Plasmid allowing gene expression from inducible P-lambda promoter Invitrogen
pDML995 A derivative of the Bacillus/E. coli shuttle vector pMK4 A. Brans (unpublished)
carrying the wild-type B. licheniformis 749 bla divergon
pCIP151 pCRScript derivative carrying the blaI-WT coding sequence This study
pCIP152 pLex derivative allowing blaI-WT expression This study
pCIP153 A derivative of pCIP151 encoding the blaI-GM2 gene This study
pCIP154 pET22b derivative allowing blaI-GM2 expression This study
pCIP155 A derivative of pDML995 with an unique SnaBI site in bla divergon This study
pCIP156 pUC18 derivative carrying the PstI–SacI fragment of the pDML995 bla divergon This study
pCIP157 A derivative of pCIP156 in which the blaI-GM2 mutation has been introduced This study
pCIP158 A derivative of Bacillus/E. coli shuttle vector pCIP155 carrying This study
a bla divergon containing the blaI-GM2 mutation
pDML1268 A derivative of Bacillus/E. coli shuttle vector pMK4 carrying a bla K. Benlafya (unpublished)
divergon containing the blaR1 mutation H212EXXH Æ AAXXA (blaR1–)
pCIP159 A derivative of Bacillus/E. coli shuttle vector pCIP155 carrying This study
a bla divergon containing the blaI-GM2 and blaR1-A212AxxA mutations
amplified fragment was ligated to the pCRScript plasmid to
give pCIP151. The identity of the amplified DNA segment 
was confirmed by determination of its nucleotide sequence.
pCIP151 was digested with NdeI and EcoRI, and the frag-
ment corresponding to blaI was purified by agarose gel 
electrophoresis and ligated to the pLex vector digested with
the same restriction endonucleases to give pCIP152.
Plasmid pCIP153 is a derivative of plasmid pCIP151, which
contains the BlaI M97 V98 Æ I L mutation. The mutation was
introduced using the QuickChange kit (Stratagene) and the
following two primers: 5¢-GGAACTCTTAATTCGATATTAT
TAAAC-3¢ (BlaIGM2+) and 5¢-GTTTAATAATATCGAATTAA
GAGTTCC-3¢ (BlaIGM2–). The NdeI–EcoRI fragment of
pCIP153 containing blaI-GM2 was inserted into pET22b+
(Novagen) to produce the BlaI-GM2 overexpression plasmid
pCIP154.
Plasmid pCIP155 is a derivative of pDML995, in which the
SnaBI site in the bla divergon is unique. To construct this
plasmid, pDML995 was digested with BspEI and SmaI to
remove the second SnaBI site present in pDML995, treated
with Klenow polymerase and self-ligated. To substitute the
wild-type blaI gene for blaI-GM2 in pCIP155, a fragment 
carrying the wild-type blaI gene was obtained by digestion of
pDML995 with SacI–PstI and cloned into the SacI–PstI site
of pUC18 to construct pCIP156. The BlaI-GM2 mutation 
was introduced in pCIP156 as described above to generate
pCIP157, and the mutated SnaBI–SacI fragment was cloned
in pCIP155 to produce pCIP158. To construct the double
mutant divergon, blaI-GM2 and blaR1 H212EXXH Æ AAXXA,
the SnaBI–SacI fragment carrying the BlaI-GM2 mutation
was cloned in pDML1268, carrying the BlaR1 mutation, to
generate pCIP159.
Restriction endonucleases, sequencing enzymes and Tth
or Pwo DNA polymerases were purchased from Amersham
Pharmacia and Gibco BRL. Oligonucleotides and primers for
DNA sequencing were obtained from Amersham Pharmacia.
Routine DNA manipulations were carried out as described by
Sambrook et al., and B. subtilis was transformed according
to the method of Msadek et al. (1998). DNA sequencing of
the mutagenized fragment was performed by the dideoxy
chain termination method using an ALFexpress DNA
sequencer (Amersham Pharmacia).
Luria–Bertani (LB) medium was used as a rich liquid for
both E. coli and Bacillus and as a solid medium (1.5% agar).
Recombinant E. coli and Bacillus strains were selected 
with 100 mg ml–1 ampicillin and 7 mg ml–1 chloramphenicol
respectively.
Expression and purification of BlaI-WT and BlaI-GM2
The purification of the repressors was adapted from the
method of Grossman and Lampen (1987). The E. coli
GI724/pCIP152 strain was grown in a tryptophan-defective
medium in the presence of ampicillin (100 mg ml–1) at 30∞C.
At an absorbance of 0.8 at 600 nm (A600), the expression 
of BlaI-WT was induced by the addition of 100 mg ml–1
tryptophan. After 3 h of induction at 37∞C, the cells were 
harvested, washed and resuspended in lysis buffer [15 mM
Tris-HCl (pH 7.5), 10 mM MgSO4, 100 mM KCl and 1 mM
Pefabloc (Boehringer)]. Cells were disrupted by passage
through an Inceltech disintegrator (basic Z model). After 
the addition of benzonase (500 U l–1 culture; Eurogentec), 
the soluble cell fraction was obtained as the supernatant 
after 45 min of centrifugation at 9000 g and 4∞C. After the
addition of glycerol (10% final concentration), the solution
was diluted with lysis buffer supplemented with glycerol to
reach a protein concentration of 12 mg ml–1. The diluted 
solution was 45% saturated in ammonium sulphate. The pH
was adjusted to 7.5, and proteins were precipitated overnight
at 4∞C. After centrifugation, the resulting supernatant con-
taining BlaI was dialysed against the loading buffer (50 mM
HEPES, pH 7.6, 1 mM EDTA and 5% glycerol). The dialysed
solution was submitted to ion-exchange chromatography on
an S-sepharose fast flow column (2.6 ¥ 40 cm; Amersham
Pharmacia), and the adsorbed BlaI-WT was eluted by a step
gradient (200 ml of loading buffer supplemented with 0.5 
and 0.58 M NaCl respectively). To obtain a purity > 95%, an 
additional chromatography was performed on a HiTrap
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heparin column (5 ml; Amersham Pharmacia) equilibrated
with 50 mM HEPES, pH 7.6, 1 mM EDTA, 5% glycerol and
0.2 M NaCl. BlaI was eluted with a linear NaCl gradient
ranging from 0.2 to 2 M.
Overexpression of BlaI-GM2 was achieved using E. coli
BL21 (DE3) transformed by pCIP154. The recombinant strain
was grown in LB. When the culture reached an A600 of 0.8,
expression of BlaI-GM2 was induced by 1 mM IPTG, and the
culture was grown for an additional 3 h. The purification of
BlaI-GM2 was performed as described for BlaI, except that
the ammonium sulphate precipitation was carried out at 30%
saturation.
b-Lactamase induction
Bacillus licheniformis and recombinant Bacillus strains were
grown in LB at 37∞C until A600 reached 0.8. Cephalosporin C
was added at a final concentration of 2.5 mg ml–1, and the
incubation was continued at 37∞C for 4 h.
b-Lactamase activity was measured spectrophotometri-
cally with nitrocefin (Becton Dickinson) and expressed as
nmol of substrate hydrolysed min–1 per unit of cell density.
Cell densities were determined by measuring the A600.
Anti-BlaI antibodies and Western blot (immunoblot)
analysis
A polyclonal anti-BlaI antiserum was generated by immu-
nizing New Zealand white rabbits with purified BlaI-WT
(Centre d’Economie Rurale et d’Hormonologie de Marloie).
The crude serum was used in immunoblotting at a final 
dilution of 1:200.
Ten millilitres of induced or uninduced B. licheniformis or
recombinant B. subtilis strains was sedimented by centrifu-
gation and resuspended in 200 ml of 50 mM Tris-HCl, pH 7, 
1mM EDTA and 1 mM Pefabloc. Bacterial cells were dis-
rupted by sonication in a Branson ultrasonic disintegrator at
an amplitude of 6 mm for three 30 s bursts. Soluble cell frac-
tions were obtained as supernatants after centrifugation of
the lysates. Protein concentrations in cellular extracts were
determined by the 2-bicinchoninic acid assay (BCA protein
assay; Pierce).
Proteins (25–50 mg) were separated by SDS–PAGE (15%)
and electroblotted onto a polyvinylidene difluoride (PVDF)
membrane. Immunoblot analysis using polyclonal anti-BlaI
rabbit antibodies and the detection of rabbit antibodies on
blots were carried out using goat alkaline phosphatase-
conjugated anti-rabbit antibodies and a colour reaction 
with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue
tetrazolium, as instructed by the manufacturer (Bio-Rad;
immunoblot alkaline phosphatase assay system). The
Benchmark prestained protein ladder (Gibco BRL) was used
as molecular ratio (Mr) standard.
Dithiobis(succimidylpropionate) (DSP) cross-linking
The cross-linking of pure BlaI-WT or BlaI-GM2 was carried
out as recommended by the supplier (Pierce). Cell pellets
from 100 ml of induced or uninduced cultures were sus-
pended in 500 ml of ice-cold cross-linking buffer (50 mM
sodium phosphate, pH 6.5, 50 mM KCl and 1 mM EDTA) and
disrupted by sonication as described above. The soluble 
cellular extracts were recovered by centrifugation, and the
protein concentrations were determined using the BCA
assay. Total proteins (50 mg) were incubated for 2 h at room
temperature with DSP concentrations ranging from 0.2 to 
2 mM. The cross-linking reaction was stopped by the addition
of Tris base at a final concentration of 20 mM. Before
SDS–PAGE, the samples were denatured by the addition of
Laemmli denaturing buffer without mercaptoethanol. After
electrophoresis, BlaI was detected by the immunoblotting
procedure described above.
DNA-binding assay
For DNA-binding assays, induced or uninduced cells from
100 ml of culture were collected by centrifugation, and the
pellet was resuspended in 500 ml of ice-cold DNA-binding
buffer [10 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM EDTA, 5%
glycerol and 50 mg ml–1 bovine serum albumin (BSA, protease
and nuclease free)]. After sonication, the soluble cellular
extract was recovered by centrifugation, and the DNA-
binding assay was carried out using an ALFexpress DNA
sequencer and the fluorescent double-stranded oligonu-
cleotide OP1 (5¢-Cy5-GCATTTAAATCTTACATATGTAATAC
TTTC-3¢) as described previously (Filée et al., 2001).
Two-dimensional electrophoresis
Cells from 10 ml of induced or uninduced cultures were har-
vested by centrifugation, and the pellets were resuspended
in 250 ml of Milli-Q water and sonicated as described above.
The soluble extracts were recovered by centrifugation, and
the protein concentration was adjusted to 5 mg ml–1 by the
addition of Milli-Q water. Eighty microlitres of denaturing
buffer [7 M urea, 2 M thiourea, 4% CHAPS, 6.5 mM dithio-
threitol (DTT) and 0.8% pharmalytes (Amersham Pharma-
cia)] was added to a 20 ml sample. The mixture was incubated
for 2 h on ice and centrifuged at 25 000 g for 30 min to elimi-
nate insoluble material. Cellular extracts (100 ml) from unin-
duced and induced cells were pooled and loaded onto an
Immobiline Drystrip (pH 6–11, 18 cm; Amersham Pharmacia).
The isoelectric focusing run was performed at 20∞C on a 
Multiphor II (Amersham Pharmacia) according to the follow-
ing programme: step 1, the voltage was increased from 1 to
300 V over 1 min; step 2, 300 V for 4.5 h; step 3, the voltage
was increased from 300 to 3500 V over 30 min; step 4, 3500
V for 23 h. Thereafter, the gel was incubated for 15 min in the
denaturing buffer (50 mM Tris-HCl, pH 7.8, 6 M urea, 2% SDS
and 30% glycerol), followed by a second incubation in fresh
denaturing buffer supplemented with iodoacetamide (140 mM
final concentration). The SDS–PAGE run was performed 
at 15∞C with an acrylamide gel gradient from 8% to 18%
(Amersham Pharmacia). BlaI was detected by the Western
blotting procedure described above.
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